Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05740358 · ClinicalTrials.gov registry record

Liver Cirrhosis Network Cohort Study

A clinical trial of Cirrhosis and Cirrhosis, Liver, sponsored by Northwestern University.

Active
Registry status
1,222
Enrollment target
14
Study locations

NCT05740358 is a study of Cirrhosis and Cirrhosis, Liver that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 1,222 participants, below the 90,386-participant average among 53 other Cirrhosis trials with a reported enrollment target (99% lower). The trial reports 14 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05740358, a study of Cirrhosis and Cirrhosis, Liver, is active but no longer recruiting, sponsored by Northwestern University.

ACTIVE NOT RECRUITING
Registry status
1,222 participants
Enrollment target
14
Study locations

Study Summary

Liver Cirrhosis Network (LCN) Cohort Study is an observational study designed to identify risk factors and develop prediction models for risk of decompensation in adults with liver cirrhosis. LCN Cohort Study involves multiple institutions and an anticipated 1200 participants. Enrolled participants will have study visits every 6 months (180 days), with opportunities to complete specific visit components via telehealth or remotely. Visits will include collection of questionnaire data and the in-person visits will include questionnaires, physical exams, imaging, and sample collection.

Conditions Studied

Cirrhosis Cirrhosis, Liver Cirrhosis Early Cirrhosis Due to Hepatitis B Cirrhosis Advanced Cirrhosis Infectious Cirrhosis Alcoholic Cirrhosis Due to Hepatitis C Cirrhosis, Biliary Cirrhosis Cryptogenic

Study Locations (14)

California

  • University of California San Diego NAFLD Research Center - La Jolla
  • Keck Medical Center of USC - Los Angeles
  • LAC + USC Medical Center - Los Angeles
  • UCSF/Zuckerberg San Francisco General Hospital and Trauma Center - San Francisco
  • UCSF Medical Center - San Francisco

New York

  • New York Presbyterian/Weill Cornell - New York
  • Columbia University Iriving School of Medicine - New York

Virginia

  • Central Virginia Veterans Healthcare System - Richmond
  • Virginia Commonwealth University - Richmond

Florida

  • University of Miami Health System - Miami

Michigan

  • University of Michigan - Ann Arbor

Minnesota

  • Mayo Clinic - Rochester

North Carolina

  • Duke Liver Center - Durham

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 1,222 participants
Start Date 2022-11-18
Est. Completion 2030-10-24

Sponsor

Northwestern University

1,209 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05740358

The ClinicalTrials.gov registry entry for NCT05740358 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,222 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 90,386-participant average among 53 other Cirrhosis trials with a reported enrollment target (99% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Cirrhosis appearing as the primary indexed condition, and to 0 interventions.

NCT05740358 reports 14 study locations spanning 8 distinct geographic areas - top geographies include California, New York, Virginia.

Frequently Asked Questions

What is clinical trial NCT05740358 about?

NCT05740358 is a clinical study titled "Liver Cirrhosis Network Cohort Study". Liver Cirrhosis Network (LCN) Cohort Study is an observational study designed to identify risk factors and develop prediction models for risk of decompensation in adults with liver cirrhosis. LCN Cohort Study involves multiple institutions and an anticipated 1200 participants. Enrolled participants ...

What is the current status of trial NCT05740358?

This trial is currently active not recruiting. The enrollment target is 1,222 participants. The study started on 2022-11-18. Estimated completion is 2030-10-24.

What conditions does trial NCT05740358 study?

This clinical trial studies the following conditions: Cirrhosis, Cirrhosis, Liver, Cirrhosis Early, Cirrhosis Due to Hepatitis B, Cirrhosis Advanced.

Who is sponsoring clinical trial NCT05740358?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05740358 being conducted?

This trial has 14 study locations across California, Florida, Michigan, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cirrhosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cirrhosis

All registered trials for this condition

Cirrhosis, Liver

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.